Efficacy Study of Aminoflavone Prodrug to Treat Breast Cancer
NCT01015521 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2010-11-03
Summary
This is a phase II study to assess the efficacy of Aminoflavone prodrug in triple negative and ER+ breast cancer.
Conditions
- Breast Neoplasm
Interventions
- DRUG
-
Aminoflavone Prodrug
Aminoflavone Prodrug administered D1, D8 of 21-day cycle
Sponsors & Collaborators
-
Tigris Pharmaceuticals
lead INDUSTRY
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-04-30
- Primary Completion
- 2012-12-31
More Related Trials
-
Eradication of Malignant Carcinoma in the Breast Tissue
NCT02286778 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Amonafide in Treating Women With Metastatic Breast Cancer That Has Progressed After Previous Chemotherapy
NCT00074100 ·Status: COMPLETED ·Phase: PHASE2
-
Olaparib in the Treatment of BRCA1/2 Unmutated and BRCA1 Promoter Methylated Recurrent and Metastatic Triple-negative Breast Cancer
NCT05522491 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study of AL101 Monotherapy in Patients With Notch Activated Triple Negative Breast Cancer
NCT04461600 ·Status: TERMINATED ·Phase: PHASE2
-
A Phase 1-2, XIAP Antisense AEG35156 With Weekly Paclitaxel in Patients With Advanced Breast Cancer
NCT00558545 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast
NCT04009044 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Valproic Acid in Combination With FEC100 for Primary Therapy in Patients With Breast Cancer
NCT01010854 ·Status: TERMINATED ·Phase: PHASE2
-
Study of Pralatrexate in Female Patients With Previously-treated Breast Cancer
NCT01118624 ·Status: COMPLETED ·Phase: PHASE2
-
Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer
NCT00002777 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
NCT02202746 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of Rucaparib Administered With Radiation in Patients With Triple Negative Breast Cancer With an Incomplete Response Following Chemotherapy
NCT03542175 ·Status: COMPLETED ·Phase: PHASE1
-
Lapatinib Ditosylate and Akt Inhibitor MK2206 in Treating Women With Metastatic Breast Cancer
NCT01281163 ·Status: TERMINATED ·Phase: PHASE1
-
A Study to Evaluate TAlazoparib, Radiotherapy and Atezolizumab in gBRCA 1/2 Negative Patients With PD-L1+ Metastatic Triple Negative Breast Cancer
NCT04690855 ·Status: TERMINATED ·Phase: PHASE2
-
Phase II Single Arm Trial of Low Dose Capecitabine in Patients With Advanced Breast Cancer
NCT06105684 ·Status: RECRUITING ·Phase: PHASE2
-
Phase II Study of Capecitabine and Weekly Docetaxel Followed by Capecitabine Maintenance for Patients With Metastatic Breast Carcinoma
NCT00225056 ·Status: TERMINATED ·Phase: PHASE2
-
Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast Cancer
NCT01525966 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
ANG1005 in Leptomeningeal Disease From Breast Cancer
NCT03613181 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer
NCT03975647 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Breast Cancer
NCT00802945 ·Status: COMPLETED ·Phase: PHASE2
-
Tipifarnib, Doxorubicin, and Cyclophosphamide in Treating Women With Locally Advanced Breast Cancer
NCT00049114 ·Status: COMPLETED ·Phase: PHASE2
-
Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis
NCT03691493 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Eniluracil + 5-Fluorouracil (5-FU) + Leucovorin Versus Capecitabine in Metastatic Breast Cancer
NCT01231802 ·Status: UNKNOWN ·Phase: PHASE2
-
Saracatinib in Treating Patients With Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed By Surgery
NCT00559507 ·Status: COMPLETED ·Phase: PHASE2
-
Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced, Metastatic, or Recurrent Triple Negative Invasive Breast Cancer
NCT01151449 ·Status: TERMINATED ·Phase: PHASE2
-
Olaparib in Locally Advanced ER, PgR and HER2 Negative (Triple Negative) and in Locally Advanced Germline BRCA Mutation-positive Breast Cancer Patients
NCT02681562 ·Status: UNKNOWN ·Phase: PHASE2